Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bonnie Ky"'
Autor:
Kasey J. Leger, Michael J. Absalon, Biniyam G. Demissei, Amanda M. Smith, Robert B. Gerbing, Todd A. Alonzo, Hari K. Narayan, Betsy A. Hirsch, Jessica A. Pollard, Bassem I. Razzouk, Kelly D. Getz, Richard Aplenc, E. Anders Kolb, Bonnie Ky, Todd M. Cooper
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionAnthracyclines are effective in treating acute myeloid leukemia (AML) but limited by cardiotoxicity. CPX-351, a liposomal daunorubicin and cytarabine, may provide therapeutic benefit with less cardiotoxicity. Acute changes in left ventric
Externí odkaz:
https://doaj.org/article/4f7d5c7ff98a44ee954f1d19f9442a1c
Autor:
Kasey J. Leger, Nora Robison, Hari K. Narayan, Amanda M. Smith, Tenaadam Tsega, Jade Chung, Amber Daniels, Zhen Chen, Virginia Englefield, Biniyam G. Demissei, Benedicte Lefebvre, Gemma Morrow, Ilona Dizon, Robert B. Gerbing, Reena Pabari, Kelly D. Getz, Richard Aplenc, Jessica A. Pollard, Eric J. Chow, W. H. Wilson Tang, William L. Border, Ritu Sachdeva, Todd A. Alonzo, E. Anders Kolb, Todd M. Cooper, Bonnie Ky
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundPediatric acute myeloid leukemia (AML) therapy is associated with substantial short- and long-term treatment-related cardiotoxicity mainly due to high-dose anthracycline exposure. Early left ventricular systolic dysfunction (LVSD) compromis
Externí odkaz:
https://doaj.org/article/b99055bf1d704eadae2a445572632039
Autor:
Srilakshmi Vallabhaneni, Yue Wang, Ying Zhang, Amanda Smith, Wei Zou, Steven Feigenberg, John Plastaras, Gary Freedman, Walter R. T. Witschey, Bonnie Ky, Yuchi Han
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundChest radiation therapy (RT) is known to be associated with cardiotoxicity. However, the changes in myocardial tissue characterization with radiation-induced cardiotoxicity are not well-understood.ObjectivesThis study sought to assess the c
Externí odkaz:
https://doaj.org/article/6dc2632192ab4d8aa781f96f9c2f09d4
Autor:
Biniyam G. Demissei, WenJian Lv, Nicholas S. Wilcox, Karyn Sheline, Amanda M. Smith, Kathleen M. Sturgeon, Chris McDermott-Roe, Kiran Musunuru, Bénédicte Lefebvre, Susan M. Domchek, Payal Shah, Bonnie Ky
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectiveAnimal models suggest that BRCA1/2 mutations increase doxorubicin-induced cardiotoxicity risk but data in humans are limited. We aimed to determine whether germline BRCA1/2 mutations are associated with cardiac dysfunction in breast cancer s
Externí odkaz:
https://doaj.org/article/6a2d2f18394d4f2da6ca9fa01364cce5